Quarterly report · Q3
4886.TEDINET S100Q4CE
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥56.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.2bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥5.0bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥4.7bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥5.2bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.9bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.4bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.8bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥90.8bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥83.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥87.5bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.7bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥34.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥54.1bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥48.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.5bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥148.19 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.97 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.22 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥143.76 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.1 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥196m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥155m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥26m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥41m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥41m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥767m |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥417m |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥41.9bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥41.9bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥5.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥158m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥116m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥42m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥41m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥41m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥495m |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥329m |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥44.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥44.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥5.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 340
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)清陽監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)野中 信男 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中市 俊也 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)槇田 憲一郎 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 44179000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 47259000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 56607000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 4790000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 5246000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 4880000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 4082000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 4183000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 4290000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 4256000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 5538000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 4982000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 48412000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 54080000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 48892000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 87536000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 90794000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 83297000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 143.76 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 148.19 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 151.22 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.553 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.596 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.587 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 242.10 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 64.97 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30563199 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 30563199 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 30563199 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 30563199 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 2269100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 28273300 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 282733 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 20799 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 30563199 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 282733 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 2269100 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |